Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer
{{output}}
Objectives: Dossiers submitted for early benefit assessments in Germany also provide information on the precise determination of the target population (patients eligible for a drug). The situation is complex for non-small-cell lu... ...
